Kai-Wei Liao1, Chia-Huang Chang1, Ming-Song Tsai2, Ling-Chu Chien3, Ming-Yi Chung4, I-Fang Mao5, Yen-An Tsai1, Mei-Lien Chen6. 1. Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang Ming University, Taipei, Taiwan. 2. Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan; School of Medicine, Fu Jen Catholic University, Taipei, Taiwan; School of Medicine, Taipei Medical University, Taipei, Taiwan. 3. School of Public Health, Taipei Medical University, Taipei, Taiwan. 4. Department of Life Sciences, Institute of Genome Sciences, National Yang Ming University, Taipei, Taiwan. 5. Department of Occupational Safety and Health, Chung Shan Medical University, Taichung, Taiwan. 6. Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang Ming University, Taipei, Taiwan. Electronic address: mlchen@ym.edu.tw.
Abstract
BACKGROUND: Arsenic exposure is a global health concern. Several studies have focused on chronic arsenic exposure in adults; however, limited data are available regarding the potential adverse effects of prenatal exposure on fetuses and neonates. OBJECTIVES: To assess which time point maternal arsenic exposure may influence the fetus during pregnancy and birth outcomes. METHODS: In this study, total arsenic concentrations were analyzed in urine samples collected from 130 women with singleton pregnancies (22-45years old) in Taiwan from March to December of 2010. All fetal biometric measurements in each trimester period and birth outcomes at delivery were obtained. We applied a generalized estimating equation model and multivariate regression models to evaluate the associations between maternal urinary total arsenic (UtAs) exposure during pregnancy, fetal biometric measurements, and neonatal birth outcomes. RESULTS: We observed statistically significant correlations between maternal UtAs levels and the fetal biparietal diameter over all three trimesters (β=-1.046mm, p<0.05). Multiple regression analyses showed a negative association between maternal UtAs levels and chest circumference in the first trimester (β=-0.721cm, p<0.05), and second-trimester UtAs exposure was associated with decreases in birth weight (β=-173.26g, p<0.01), head circumference (β=-0.611cm, p<0.05), and chest circumference (β=-0.654cm, p<0.05). Dose-response relationships were also observed for maternal UtAs exposure and birth outcomes. CONCLUSIONS: We identified a negative relationship between maternal UtAs levels during pregnancy, fetal development, and neonatal birth outcomes. These findings should be confirmed in future studies with large sample sizes.
BACKGROUND:Arsenic exposure is a global health concern. Several studies have focused on chronic arsenic exposure in adults; however, limited data are available regarding the potential adverse effects of prenatal exposure on fetuses and neonates. OBJECTIVES: To assess which time point maternal arsenic exposure may influence the fetus during pregnancy and birth outcomes. METHODS: In this study, total arsenic concentrations were analyzed in urine samples collected from 130 women with singleton pregnancies (22-45years old) in Taiwan from March to December of 2010. All fetal biometric measurements in each trimester period and birth outcomes at delivery were obtained. We applied a generalized estimating equation model and multivariate regression models to evaluate the associations between maternal urinary total arsenic (UtAs) exposure during pregnancy, fetal biometric measurements, and neonatal birth outcomes. RESULTS: We observed statistically significant correlations between maternal UtAs levels and the fetal biparietal diameter over all three trimesters (β=-1.046mm, p<0.05). Multiple regression analyses showed a negative association between maternal UtAs levels and chest circumference in the first trimester (β=-0.721cm, p<0.05), and second-trimester UtAs exposure was associated with decreases in birth weight (β=-173.26g, p<0.01), head circumference (β=-0.611cm, p<0.05), and chest circumference (β=-0.654cm, p<0.05). Dose-response relationships were also observed for maternal UtAs exposure and birth outcomes. CONCLUSIONS: We identified a negative relationship between maternal UtAs levels during pregnancy, fetal development, and neonatal birth outcomes. These findings should be confirmed in future studies with large sample sizes.
Authors: Sharia M Ahmed; Brie N Noble; Sakila Afroz Joya; M Omar Sharif Ibn Hasan; Pi-I Lin; Mohammad L Rahman; Golam Mostofa; Quazi Quamruzzaman; Mahmudur Rahman; David C Christiani; Molly L Kile Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Caitlin G Howe; Shohreh F Farzan; Erika Garcia; Thomas Jursa; Ramsunder Iyer; Kiros Berhane; Thomas A Chavez; Tahlia L Hodes; Brendan H Grubbs; William E Funk; Donald R Smith; Theresa M Bastain; Carrie V Breton Journal: Environ Res Date: 2020-02-27 Impact factor: 6.498
Authors: Zorimar Rivera-Núñez; Pahriya Ashrap; Emily S Barrett; Deborah J Watkins; Amber L Cathey; Carmen M Vélez-Vega; Zaira Rosario; José F Cordero; Akram Alshawabkeh; John D Meeker Journal: Environ Int Date: 2020-12-13 Impact factor: 9.621